Cargando…
More targets, more pathways and more clues for mutant p53
Mutations in the transcription factor p53 are among the most common genetic alterations in human cancer, and missense p53 mutations in cancer cells can lead to aggressive phenotypes. So far, only few studies investigated transcriptional reprogramming under mutant p53 expression as a means to identif...
Autores principales: | Garritano, S, Inga, A, Gemignani, F, Landi, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740285/ https://www.ncbi.nlm.nih.gov/pubmed/23817466 http://dx.doi.org/10.1038/oncsis.2013.15 |
Ejemplares similares
-
Vitamin D in malaria: more hypotheses than clues
por: Bivona, Giulia, et al.
Publicado: (2019) -
More Is More
por: Potter, Polyxeni
Publicado: (2013) -
Wild-type p53 oligomerizes more efficiently than p53 hot-spot mutants and overcomes mutant p53 gain-of-function via a “dominant-positive” mechanism
por: Walerych, Dawid, et al.
Publicado: (2018) -
When more is not more
por: Wells, William A.
Publicado: (2002) -
P1155: MORE PRECISE RISK STRATIFICATION FOR TP53 MUTANT DIFFUSE LARGE B CELL LYMPHOMA
por: Du, Kai-Xin, et al.
Publicado: (2023)